Publication | Closed Access

Designing idiosyncratic hmPCL -siRNA nanoformulated capsules for silencing and cancer therapy

NanoparticlesNanomedicineCancer TherapyEngineeringIdiosyncratic Hmpcl -SirnaTherapeutic NanomaterialsPolymer-drug ConjugateNano-drug DeliveryTumor TargetingBiomedical EngineeringRadiation OncologyCancer Research